Astal Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/05/2025 ,inter alia, to consider and approve the audited standalone financial ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Astal Laboratories Limited has informed BSE that its Board of Directors will meet on Monday, 19 May 2025 at the corporate office in Hyderabad. The meeting will consider and approve the audited standalone financial results for the quarter and year ended March 31, 2025, along with the auditor's limited review report. It will also approve the audited standalone financial statements for FY 2024-25. Additionally, the Board will appoint the Internal Auditor for FY 2025-26 and the Secretarial Auditor for a five-year term. The trading window for designated persons has been closed since April 1, 2025 and will reopen 48 hours after the board meeting concludes.
This is a routine advance intimation of an upcoming board meeting — no actual results or decisions have been disclosed yet. Investors should watch for the audited FY25 results announcement after 19 May for actual financial performance.